Phase I/II Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukemia
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.265
https://www.valueinhealthjournal.com/article/S1098-3015(17)30599-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
244
First Page :
A445
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30599-5&doi=10.1016/j.jval.2017.08.265